Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

BioAro, a global leader in precision health and genomics, will unveil its groundbreaking AI-powered PanOmiQ platform at the ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new study.

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Alec Kimmelman, MD, PhD, and Shridar Ganesan, MD, PhD, discuss the institution's new molecular oncology program.

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...